首页> 外文OA文献 >Profiling of Human Antibody Responses to Chlamydia trachomatis Urogenital Tract Infection Using Microplates Arrayed with 156 Chlamydial Fusion Proteins
【2h】

Profiling of Human Antibody Responses to Chlamydia trachomatis Urogenital Tract Infection Using Microplates Arrayed with 156 Chlamydial Fusion Proteins

机译:人类抗体对沙眼衣原体泌尿生殖道感染的反应分析使用156衣原体融合蛋白阵列的微孔板。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The available chlamydial genome sequences have made it possible to comprehensively analyze host responses to all chlamydial proteins, which is essential for further understanding of chlamydial pathogenesis and development of effective chlamydial vaccines. Microplates arrayed with 156 Chlamydia trachomatis fusion proteins were used to evaluate antibody responses in women urogenitally infected with C. trachomatis. Based on both the antibody recognition frequency and titer, seven chlamydial antigens encoded by open reading frames (ORFs) CT089, CT147, CT226, CT681, CT694, CT795, and CT858, respectively, were identified as relatively immunodominant; six of these are encoded by hypothetical ORFs. Antibody binding to these chlamydial fusion proteins was blocked by C. trachomatis-infected but not by normal HeLa cell lysates or irrelevant bacterial lysates. These results have revealed novel immune-reactive chlamydial antigens, not only indicating that the hypothetical ORF-encoded proteins are expressed during chlamydial infection in humans but also providing the proof of principle that the fusion protein-based approach can be used to profile human immune responses to chlamydial infection at the whole-genome scale.
机译:可用的衣原体基因组序列使全面分析宿主对所有衣原体蛋白的反应成为可能,这对于进一步了解衣原体的发病机理和开发有效的衣原体疫苗至关重要。排列有156种沙眼衣原体融合蛋白的微孔板用于评估泌尿生殖道沙眼衣原体感染妇女的抗体反应。根据抗体识别频率和滴度,分别确定了由开放阅读框(ORF)CT089,CT147,CT226,CT681,CT694,CT795和CT858编码的7种衣原体抗原具有相对免疫优势。其中六个由假设的ORF编码。沙眼衣原体感染可阻断抗体与这些衣原体融合蛋白的结合,但正常的HeLa细胞裂解物或无关的细菌裂解物不会阻断抗体的结合。这些结果揭示了新型的免疫反应性衣原体抗原,不仅表明假设的ORF编码蛋白在人衣原体感染期间表达,而且提供了基于融合蛋白的方法可用于分析人免疫应答的原理证明。全基因组规模的衣原体感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号